Hmingthansanga Victor, Singh Nidhi, Banerjee Superna, Manickam Sivakumar, Velayutham Ravichandiran, Natesan Subramanian
Department of Pharmaceutics, Advanced Formulation Laboratory, National Institute of Pharmaceutical Education and Research Kolkata, Chunilal Bhawan, 168, Maniktala Main Road, Kolkata 700054, India.
Petroleum and Chemical Engineering, Faculty of Engineering, Universiti Teknologi Brunei, Bandar Seri Begawan BE1410, Brunei.
Pharmaceutics. 2022 Dec 15;14(12):2818. doi: 10.3390/pharmaceutics14122818.
The delivery of drugs via transdermal routes is an attractive approach due to ease of administration, bypassing of the first-pass metabolism, and the large skin surface area. However, a major drawback is an inability to surmount the skin's stratum corneum (SC) layer. Therefore, techniques reversibly modifying the stratum corneum have been a classical approach. Surmounting the significant barrier properties of the skin in a well-organised, momentary, and harmless approach is still challenging. Chemical permeation enhancers (CPEs) with higher activity are associated with certain side effects restricting their advancement in transdermal drug delivery. Furthermore, complexity in the interaction of CPEs with the skin has led to difficulty in elucidating the mechanism of action. Nevertheless, CPEs-aided transdermal drug delivery will accomplish its full potential due to advancements in analytical techniques, synthetic chemistry, and combinatorial studies. This review focused on techniques such as drug-vehicle interaction, vesicles and their analogues, and novel CPEs such as lipid synthesis inhibitors (LSIs), cell-penetrating peptides (CPPs), and ionic liquids (ILs). In addition, different types of microneedles, including 3D-printed microneedles, have been focused on in this review.
由于给药方便、可绕过首过代谢以及皮肤表面积大,经皮给药是一种很有吸引力的方法。然而,一个主要缺点是无法跨越皮肤的角质层(SC)。因此,可逆地改变角质层的技术一直是一种经典方法。以一种有序、瞬时且无害的方式克服皮肤显著的屏障特性仍然具有挑战性。活性较高的化学渗透促进剂(CPEs)存在某些副作用,限制了它们在经皮给药中的应用。此外,CPEs与皮肤相互作用的复杂性导致难以阐明其作用机制。尽管如此,由于分析技术、合成化学和组合研究的进展,CPEs辅助的经皮给药将发挥其全部潜力。本综述重点关注了药物-载体相互作用、囊泡及其类似物等技术,以及脂质合成抑制剂(LSIs)、细胞穿透肽(CPPs)和离子液体(ILs)等新型CPEs。此外,本综述还关注了不同类型的微针,包括3D打印微针。